CompletedNCT02532686
DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia
This study has finished and is no longer accepting participants.
In TaichungSchizophreniaMedication studyAges 18–65
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
TerminatedNCT01712646
Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia
Official study title
The Use of Daily, Intranasal Oxytocin for the Treatment of Childhood-Onset Schizophrenia (COS), a Randomized Double-Blind Trial
This study ended early.
In BethesdaSchizophreniaMedication studyAges 10–99
CompletedNCT02187835
Decreased EEG Complexity in Schizophrenia
Official study title
Decreased EEG Complexity in Chronic Residual Schizophrenia
This study has finished and is no longer accepting participants.
In IstanbulSchizophreniaObservational studyAges 18–65
WithdrawnNCT01725334
Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia
Official study title
Deep Brain Stimulation for the Management of Treatment Refractory Negative Symptoms in Schizophrenia
This study was withdrawn before enrollment.
In TorontoSchizophreniaInterventional studyAges 25–60
CompletedNCT01689389
Quetiapine Extended-Release Use in Routine Care in France
About this title
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
Read the official source — NCT01689389Official study title
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France
This study has finished and is no longer accepting participants.
Multiple locations, including ArgenteuilSchizophrenia, BipolarityObservational studyAges 18–130
CompletedNCT04754750
Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment
Official study title
Differences in Lipid and Cognitive Change Between One-month and 3-month Paliperidone Palmitate Treatment in Stable Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 30–69
UnknownNCT04892199
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Official study title
Does the Glucagon-like Peptide-1 Receptor Agonist Semaglutide Prevent Deterioration of Metabolic State in Prediabetic or Diabetic Patients With Schizophrenia Treated With the Antipsychotic Compounds Clozapine or Olanzapine?
Current recruitment status is unconfirmed.
Multiple locations, including AarhusSchizophreniaMedication studyAges 18–65
TerminatedNCT00570063
Double Blind, 3 Week Inpatient Study Safety & Efficacy Of PF-02545920 Compared With Placebo
What is this study about?
This study evaluates the safety and effectiveness of PF-02545920 for people with schizophrenia.
This study ended early.
Multiple locations, including GlendaleSchizophreniaPlacebo comparisonAges 18–99
CompletedNCT00783185
Cannabis reduction and social skills training for psychosis
About this title
Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment
Read the official source — NCT00783185Official study title
Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis
This study has finished and is no longer accepting participants.
In KonstanzSchizophreniaBehavioural studyAges 18–65
CompletedNCT02918630
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
This study has finished and is no longer accepting participants.
In HoustonSchizophreniaMedication studyAges 18–65
CompletedNCT00204061
Amisulpride with supportive care for late early-warning signs of psychosis
About this title
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Read the official source — NCT00204061Official study title
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
This study has finished and is no longer accepting participants.
In CologneSchizophreniaMedication studyAges 14–36
CompletedNCT03730857
Early Predictors of Poor Treatment Response in people with Schizophrenia Treated With Atypical Antipsychotics
Official study title
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.